Key result
Low-dose aspirin without PPI therapy linked to life-threatening upper GI bleeding from gastric ulcers.
Why the study?
Balancing the cerebrovascular benefits of low-dose aspirin with its significant gastrointestinal bleeding risk is a critical challenge in secondary stroke prevention.
This case highlights the critical necessity of co-prescribing a proton pump inhibitor for gastroprotection in at-risk patients initiating long-term low-dose aspirin for secondary stroke prevention.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to bleeding risk without PPI; hypothesis-generating and should not change practice.
Balancing the cerebrovascular benefits of low‐dose aspirin (LDA) with its significant gastrointestinal (GI) bleeding risk is a critical challenge in secondary stroke prevention. We describe a cautionary case of a 60‐year‐old male who, 6 months after starting LDA for a transient ischemic attack (TIA), presented with a life‐threatening upper GI bleed. The patient had not been prescribed a prophylactic proton pump inhibitor (PPI). Investigations revealed a hemoglobin of 9.6 g/dL and multiple gastric ulcers on endoscopy, with negative testing for Helicobacter pylori . This case of a preventable, severe adverse event serves as a stark reminder that guideline‐recommended gastroprotection is not optional but essential. Systematic risk assessment and PPI co‐prescription in at‐risk individuals are imperative for the safe and effective use of long‐term antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
Husain et al. (2026) studied this question. Low-dose aspirin led to life-threatening upper GI bleeding due to gastric ulcers in a patient without prophylactic proton pump inhibitor therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: